Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers
- PMID:12739764
- DOI: 10.1023/a:1023238530504
Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers
Abstract
Purpose: To investigate the role of vitreous in nonviral gene delivery into retinal pigment epithelial (RPE) cells.
Methods: Human RPE cell line D407 was cultured in six-well plates. Bovine vitreous, hyaluronan, or DMEM was added on the cells. Complexes of DNA and cationic carriers (polyethyleneimine, poly-L-lysine, DOTAP liposomes) were pipetted onto the vitreous, hyaluronan, or DMEM. Cellular uptake of DNA was studied with ethidium monoazide DNA and gene expression with GFP-plasmid complexes. FITC-dextrans and FITC-polylysines were used to probe the effects of the size and cationic charge on permeation in the vitreous in a similar experimental setup. Fluorescent cells were analyzed by flow cytometry.
Results: Vitreous decreased the cellular uptake of DNA complexes 2-30 times, and GFP expression was also impaired. In hyaluronan solutions the cellular uptake of the complexes was also decreased significantly in most cases. In vitreous, cellular uptake of all FITC-dextrans decreased slightly, and uptake of poly-L-lysines was decreased substantially, whereas in hyaluronan solutions the effects were mild or nonexistent.
Conclusions: Polymeric and liposomal gene delivery is substantially limited by the vitreous. This is probably because of the size and charge of the retinal gene delivery after intravitreal injections.
Similar articles
- Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model.Pitkänen L, Pelkonen J, Ruponen M, Rönkkö S, Urtti A.Pitkänen L, et al.AAPS J. 2004 Oct 7;6(3):e25. doi: 10.1208/aapsj060325.AAPS J. 2004.PMID:15760110Free PMC article.
- Vitreous: a barrier to nonviral ocular gene therapy.Peeters L, Sanders NN, Braeckmans K, Boussery K, Van de Voorde J, De Smedt SC, Demeester J.Peeters L, et al.Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3553-61. doi: 10.1167/iovs.05-0165.Invest Ophthalmol Vis Sci. 2005.PMID:16186333
- Hyaluronic acid-modified cationic niosomes for ocular gene delivery: improving transfection efficiency in retinal pigment epithelium.Qin Y, Tian Y, Liu Y, Li D, Zhang H, Yang Y, Qi J, Wang H, Gan L.Qin Y, et al.J Pharm Pharmacol. 2018 Sep;70(9):1139-1151. doi: 10.1111/jphp.12940. Epub 2018 Jun 21.J Pharm Pharmacol. 2018.PMID:29931682
- Biodegradable Polymers for Gene Delivery.Thomas TJ, Tajmir-Riahi HA, Pillai CKS.Thomas TJ, et al.Molecules. 2019 Oct 17;24(20):3744. doi: 10.3390/molecules24203744.Molecules. 2019.PMID:31627389Free PMC article.Review.
- Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.Kirchhof B, Sorgente N.Kirchhof B, et al.Dev Ophthalmol. 1989;16:1-53.Dev Ophthalmol. 1989.PMID:2676632Review.
Cited by
- Ocular drug delivery.Gaudana R, Ananthula HK, Parenky A, Mitra AK.Gaudana R, et al.AAPS J. 2010 Sep;12(3):348-60. doi: 10.1208/s12248-010-9183-3. Epub 2010 May 1.AAPS J. 2010.PMID:20437123Free PMC article.Review.
- Charge-Converting Nanoemulsions as Promising Retinal Drug and Gene Delivery Systems.Nguyen Le NM, Zsák S, Le-Vinh B, Friedl JD, Kali G, Knoll P, Seitter HW, Koschak A, Bernkop-Schnürch A.Nguyen Le NM, et al.ACS Appl Mater Interfaces. 2022 Oct 5;14(39):44981-44991. doi: 10.1021/acsami.2c11649. Epub 2022 Sep 20.ACS Appl Mater Interfaces. 2022.PMID:36125912Free PMC article.
- Ultrasound-Mediated Ocular Drug Delivery: From Physics and Instrumentation to Future Directions.Duncan B, Al-Kassas R, Zhang G, Hughes D, Qiu Y.Duncan B, et al.Micromachines (Basel). 2023 Aug 9;14(8):1575. doi: 10.3390/mi14081575.Micromachines (Basel). 2023.PMID:37630111Free PMC article.Review.
- Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.Singh SR, Grossniklaus HE, Kang SJ, Edelhauser HF, Ambati BK, Kompella UB.Singh SR, et al.Gene Ther. 2009 May;16(5):645-59. doi: 10.1038/gt.2008.185. Epub 2009 Feb 5.Gene Ther. 2009.PMID:19194480Free PMC article.
- AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.Han Z, Conley SM, Naash MI.Han Z, et al.Invest Ophthalmol Vis Sci. 2011 May 10;52(6):3051-9. doi: 10.1167/iovs.10-6916.Invest Ophthalmol Vis Sci. 2011.PMID:21558483Free PMC article.Review.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources